Research
Schrödinger (SDGR) Stock Analysis & Research
- Latest rating
- Sell
- Latest report
- Aug 17, 2026
- Reports
- 1
- Sector
- Healthcare
Schrodinger (SDGR) develops and licenses physics-based computational software for molecule discovery and optimization, and also runs collaborative and proprietary drug discovery programs on the same platform. In 2025, software revenue was $199.5M and drug discovery revenue was $56.4M.




Weekly Performance Update — November 13, 2026
Across 247 articles, our hit rate is 72.1% and our average signal return is 15.1%, so the overall record is still solid this run. Among…
Weekly Performance Update — November 06, 2026
Across 235 articles, our hit rate is 80.2% and our average signal return is 22.4%, so the overall record is still solid this run. Among…
Weekly Performance Update — October 30, 2026
Across 219 articles, our hit rate this run is 73.7% and our average signal return is 11.9%, so the overall record is still solid. Among…
Weekly Performance Update — October 23, 2026
Across 201 articles, our hit rate is 85.9% and our average signal return is 17.2%, so the overall record is still strong this run. Among…
Weekly Performance Update — October 16, 2026
Across 188 tracked articles, directional calls show an 80% hit rate and +11.7% average signal return through October 15, 2026. Open calls remain provisional.
Weekly Performance Update — October 09, 2026
Across 192 articles, our hit rate is 73.5% and our average signal return is 5.5%, so the overall record is still solid this run. The…
Weekly Performance Update — October 02, 2026
Our track record this run is solid overall: the hit rate is 66.7% and the average signal return is 3.55%. Among the tiers with meaningful…
Weekly Performance Update — September 25, 2026
Across 160 articles, our hit rate is 64.3% and our average signal return is 0.71%, so the book is still modestly positive overall. This run,…
Weekly Performance Update — September 18, 2026
This run tracked 149 articles and 51 active long/short calls, with an average signal return of +3.9% and a hit rate of +68.6%.